Showing results (111-120 of 137) with videos related to
Sort By:
Pageof 14
Vaccine|August 21, 2012
A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemicHumberto Reynales, Pedro Astudillo, Serge de Vallière, et al.Paediatric Drugs|May 23, 2014
Awareness and utilization of reporting pathways for adverse events following immunization: online survey among pediatricians in Russia and GermanySusann Muehlhans, Max von Kleist, Tatiana Gretchukha, et al.Cancer Letters|October 11, 2014
Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapyStefan Brenner, Lukas Klameth, Juliane Riha, et al.The Journal of Clinical Investigation|May 3, 2003
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertensionVentzislav Petkov, Wilhelm Mosgoeller, Rolf Ziesche, et al.Preventive Medicine Reports|January 28, 2017
Educating parents about the vaccination status of their children: A user-centered mobile applicationLea Seeber, Tim Conrad, Christian Hoppe, et al.Vaccine|March 13, 2012
Safety reporting in developing country vaccine clinical trials-a systematic reviewSusann Muehlhans, Georgina Richard, Mohammad Ali, et al.Antiviral Therapy|February 17, 2017
Prospective surveillance of antiviral resistance in hospitalized infants less than 12 months of age with A(H3N2) influenza infection and treated with oseltamivirBarbara Rath, Xi Chen, Vera Spies, et al.The Lancet. Global Health|July 16, 2019
Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysisYou Li, Rachel M Reeves, Xin Wang, et al.Drug Safety|June 29, 2016
Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept StudyChristian Hoppe, Patrick Obermeier, Susann Muehlhans, et al.Vaccine|November 27, 2007
All that palsies is not Bell's -the need to define Bell's palsy as an adverse event following immunizationBarbara Rath, Thomas Linder, David Cornblath, et al.Pageof 14